Pluri (PLUR) Current Leases (2019 - 2025)
Pluri (PLUR) posted quarterly Current Leases of $712000.0 for Q4 2025, up 19.66% year-over-year from $595000.0 in Q4 2024, and up 5.79% quarter-over-quarter from $673000.0 in Q3 2025.
Pluri (PLUR) Current Leases (2019 - 2025) Analysis & Trends
Pluri (PLUR) has reported Current Leases for 7 consecutive years, with $712000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Leases rose 19.66% year-over-year to $712000.0; the TTM figure through Dec 2025 stood at $712000.0 (up 19.66% YoY), while the FY2025 annual figure was $659000.0, up 17.89% from the prior year.
- Current Leases improved to $712000.0 in Q4 2025 per PLUR's latest filing, from $673000.0 in the prior quarter.
- Across five years, Current Leases topped out at $826000.0 in Q1 2021 and bottomed at $401000.0 in Q3 2021.
- Historically, Current Leases has averaged $631550.0 across 5 years, with a median of $630500.0 in 2021.
- Annual changes were most pronounced in 2021 — Current Leases slumped 61.88% — and 2022, when it soared 52.37%.
- Pluri's Current Leases stood at $669000.0 in 2021, then fell by 9.57% to $605000.0 in 2022, then grew by 8.1% to $654000.0 in 2023, then fell by 9.02% to $595000.0 in 2024, then increased by 19.66% to $712000.0 in 2025.
- Business Quant data shows PLUR's Current Leases at $712000.0 in Q4 2025, $673000.0 in Q3 2025, and $659000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.56 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.72 Bn | 60.53 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.75 Bn | 53.61 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.76 Bn | 28.45 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.59 Bn | 10.19 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.63 Bn | 26.47 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.40 Bn | - | - |
| 10 | Pluri | 15.74 Mn | 3.26 Mn | 86,000.00 | 712,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 712,000.00 |
| Sep 30, 2025 | 673,000.00 |
| Jun 30, 2025 | 659,000.00 |
| Mar 31, 2025 | 599,000.00 |
| Dec 31, 2024 | 595,000.00 |
| Sep 30, 2024 | 574,000.00 |
| Jun 30, 2024 | 559,000.00 |
| Mar 31, 2024 | 675,000.00 |
| Dec 31, 2023 | 654,000.00 |
| Sep 30, 2023 | 643,000.00 |
| Jun 30, 2023 | 627,000.00 |
| Mar 31, 2023 | 627,000.00 |
| Dec 31, 2022 | 605,000.00 |
| Sep 30, 2022 | 611,000.00 |
| Jun 30, 2022 | 619,000.00 |
| Mar 31, 2022 | 669,000.00 |
| Dec 31, 2021 | 669,000.00 |
| Sep 30, 2021 | 401,000.00 |
| Jun 30, 2021 | 634,000.00 |
| Mar 31, 2021 | 826,000.00 |